BZETH is a specialized biopharmaceutical development and manufacturing partner offering
ready-to-use and customizable bioprocess buffers and solutions, cell culture media (mammalian), and enzyme-based product solutions for pharmaceutical and biotechnology
applications.
With a cGMP-focused approach and collaborative execution model, we provide solutions to advance from developmental stage to commercial readiness with reliable,
scalable, and compliant bioprocess materials for global platforms.
We ensure robust, and sustainable systems that drive healthcare innovation and
elevate patient outcomes across the globe.
At the heart of BZETH are its founders, Dr. Vaishali Rawal and Dr. Chandramauli Rawal whose shared vision, scientific expertise, and deep commitment to patient care have shaped the company from the ground up.
With a combined and vast background in medicine, pharmaceutical sciences, biotechnology research, and clinical research, they founded BZETH with a mission to provide high-quality
enzyme products, ready to use buffers and cell culture media to support pharmaceutical research, development, and manufacturing.
Our founders bring decades of applied and critical experience in drug development, regulatory affairs, and biomanufacturing which is instrumental in inculcating our
fundamental values.
Their leadership continues to inspire innovation integrity, and excellence across every aspect
of the organization-from development to production for patient support. Together, they are
building more than just an organization. They are building a legacy of care, rooted in purpose and progress.
